The U.S. Food and Drug Administration (FDA) has issued not one, but multiple warnings against the use of a transvaginal mesh, the common name for the surgical mesh used to repair a pelvic organ prolapse (POP). According to the FDA, serious complications associated with the use of transvaginal mesh are “not rare” and, even more importantly, “it is not clear that transvaginal POP repair with mesh is more effective than traditional non-mesh repair in patients with POP and it may expose patients to greater risk.” (emphasis added).
———
About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact or call 214-890-0711.
